Insights from 2023 ESMO Asia Annual Meeting
Playback speed
10 seconds
ESMO Asia 2023 Insights: "KEYNOTE-811 Study of Pembro + Trastuzumab & Chemo for HER2+ Metastatic Gastric/GEJ Adenocarcinoma"
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Sun Young Rha
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Sun Young Rha
142 views
January 17, 2024
Comments 0
Login to view comments.
Click here to Login
Gastrointestinal